Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 24% ± 6% | |
oligodendrocyte | 6 studies | 30% ± 9% | |
epithelial cell | 5 studies | 25% ± 7% | |
astrocyte | 5 studies | 27% ± 8% | |
microglial cell | 4 studies | 21% ± 5% | |
glutamatergic neuron | 4 studies | 46% ± 19% | |
oligodendrocyte precursor cell | 4 studies | 31% ± 9% | |
interneuron | 4 studies | 37% ± 21% | |
ciliated cell | 3 studies | 18% ± 1% | |
lymphocyte | 3 studies | 22% ± 5% | |
GABAergic neuron | 3 studies | 51% ± 6% | |
basal cell | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1599.02 | 1445 / 1445 | 100% | 16.33 | 183 / 183 |
breast | 100% | 1955.04 | 459 / 459 | 100% | 21.43 | 1117 / 1118 |
lung | 100% | 1741.02 | 577 / 578 | 100% | 18.42 | 1153 / 1155 |
bladder | 100% | 1778.52 | 21 / 21 | 100% | 18.61 | 502 / 504 |
thymus | 100% | 2188.14 | 653 / 653 | 100% | 24.18 | 602 / 605 |
prostate | 100% | 1981.49 | 245 / 245 | 99% | 15.90 | 499 / 502 |
brain | 99% | 1294.97 | 2626 / 2642 | 100% | 21.24 | 705 / 705 |
intestine | 100% | 2047.76 | 966 / 966 | 99% | 18.32 | 523 / 527 |
uterus | 100% | 2278.79 | 170 / 170 | 99% | 23.96 | 455 / 459 |
adrenal gland | 100% | 1463.35 | 258 / 258 | 99% | 16.96 | 227 / 230 |
ovary | 100% | 2407.19 | 180 / 180 | 99% | 12.52 | 424 / 430 |
stomach | 100% | 1523.97 | 359 / 359 | 99% | 16.57 | 282 / 286 |
pancreas | 100% | 1122.09 | 327 / 328 | 99% | 18.35 | 176 / 178 |
kidney | 100% | 1337.17 | 89 / 89 | 98% | 18.46 | 882 / 901 |
skin | 100% | 1882.99 | 1809 / 1809 | 95% | 19.58 | 449 / 472 |
liver | 100% | 807.73 | 226 / 226 | 94% | 10.35 | 381 / 406 |
blood vessel | 100% | 1600.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.74 | 29 / 29 |
spleen | 100% | 3085.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.71 | 1 / 1 |
adipose | 100% | 1893.22 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 986.29 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 992.43 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 15.17 | 71 / 80 |
peripheral blood | 81% | 1099.07 | 755 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000413 | Biological process | protein peptidyl-prolyl isomerization |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_0016018 | Molecular function | cyclosporin A binding |
Gene name | PPWD1 |
Protein name | Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8) (Spliceosome-associated cyclophilin) Peptidylprolyl isomerase domain and WD repeat containing 1 Epididymis secretory sperm binding protein (Peptidylprolyl isomerase domain and WD repeat containing 1) |
Synonyms | hCG_17862 KIAA0073 |
Description | FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding . May be involved in pre-mRNA splicing . . |
Accessions | D6R9Q1 ENST00000515447.5 ENST00000502703.5 D6RA12 ENST00000510930.5 ENST00000514172.1 ENST00000503435.5 Q96BP3 ENST00000261308.10 [Q96BP3-1] ENST00000505380.1 D6RB19 A0A384MTS1 D6RDA4 D6RHV0 H0Y8N5 D6RD43 ENST00000538977.5 [Q96BP3-2] ENST00000511908.5 F5H7P7 ENST00000535264.5 |